When Recursion launched in 2013, the fledgling biotech’s goal was to turn machine vision loose on images of cells, at scale, to better understand the biology of disease. Exscientia, founded the year ...
Announcing an artificial intelligence (AI) drug discovery partnership with Nvidia earlier this month, Recursion co-founder and CEO Chris Gibson, PhD, spoke as much about dollars as he did about drugs ...
We are in the midst of an unstructured data revolution – with 80% of data likely to be unstructured by 2025, according to IDC. The rise of advanced analytics and in particular artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback